611 related articles for article (PubMed ID: 12868573)
1. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain.
Smith LJ; Krugner-Higby L; Clark M; Wendland A; Heath TD
Comp Med; 2003 Jun; 53(3):280-7. PubMed ID: 12868573
[TBL] [Abstract][Full Text] [Related]
2. A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain.
Smith LJ; Valenzuela JR; Krugner-Higby LA; Brown C; Heath TD
Comp Med; 2006 Dec; 56(6):487-92. PubMed ID: 17219779
[TBL] [Abstract][Full Text] [Related]
3. Liposome-encapsulated oxymorphone hydrochloride provides prolonged relief of postsurgical visceral pain in rats.
Krugner-Higby L; Smith L; Clark M; Heath TD; Dahly E; Schiffman B; Hubbard-VanStelle S; Ney D; Wendland A
Comp Med; 2003 Jun; 53(3):270-9. PubMed ID: 12868572
[TBL] [Abstract][Full Text] [Related]
4. Perineural resiniferatoxin prevents the development of hyperalgesia produced by loose ligation of the sciatic nerve in rats.
Kissin I; Freitas CF; Bradley EL
Anesth Analg; 2007 May; 104(5):1210-6, tables of contents. PubMed ID: 17456676
[TBL] [Abstract][Full Text] [Related]
5. The prolonged analgesic effect of epidural ropivacaine in a rat model of neuropathic pain.
Sato C; Sakai A; Ikeda Y; Suzuki H; Sakamoto A
Anesth Analg; 2008 Jan; 106(1):313-20, table of contents. PubMed ID: 18165597
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with antiserum against dynorphin, substance P, or cholecystokinin enhances the morphine-produced anti-allodynia in the sciatic nerve ligated mice.
Wu HE; Schwasinger ET; Hong JS; Tseng LF
Neurosci Lett; 2005 Sep; 386(1):46-51. PubMed ID: 15982809
[TBL] [Abstract][Full Text] [Related]
7. Activation of extracellular signal-regulated kinase in sciatic nerve contributes to neuropathic pain after partial sciatic nerve ligation in mice.
Kiguchi N; Maeda T; Kobayashi Y; Fukazawa Y; Kishioka S
Anesth Analg; 2009 Oct; 109(4):1305-11. PubMed ID: 19762761
[TBL] [Abstract][Full Text] [Related]
8. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK
Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of liposome-encapsulated oxymorphone hydrochloride in mice after splenectomy.
Clark MD; Krugner-Higby L; Smith LJ; Heath TD; Clark KL; Olson D
Comp Med; 2004 Oct; 54(5):558-63. PubMed ID: 15575370
[TBL] [Abstract][Full Text] [Related]
10. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Christoph T; De Vry J; Tzschentke TM
Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
[TBL] [Abstract][Full Text] [Related]
11. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
12. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
13. Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain.
Nielsen CK; Lewis RJ; Alewood D; Drinkwater R; Palant E; Patterson M; Yaksh TL; McCumber D; Smith MT
Pain; 2005 Nov; 118(1-2):112-24. PubMed ID: 16154696
[TBL] [Abstract][Full Text] [Related]
14. Diphenyl diselenide attenuates acute thermal hyperalgesia and persistent inflammatory and neuropathic pain behavior in mice.
Savegnago L; Jesse CR; Pinto LG; Rocha JB; Nogueira CW
Brain Res; 2007 Oct; 1175():54-9. PubMed ID: 17888416
[TBL] [Abstract][Full Text] [Related]
15. Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs.
Smith LJ; Krugner-Higby L; Trepanier LA; Flaska DE; Joers V; Heath TD
J Vet Pharmacol Ther; 2004 Oct; 27(5):369-72. PubMed ID: 15500576
[No Abstract] [Full Text] [Related]
16. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
17. Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy.
Klass M; Gavrikov V; Drury D; Stewart B; Hunter S; Denson DD; Hord A; Csete M
Anesth Analg; 2007 Apr; 104(4):944-8. PubMed ID: 17377111
[TBL] [Abstract][Full Text] [Related]
18. Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats.
Wala EP; Sloan PA; Holtman JR
J Opioid Manag; 2011; 7(5):377-89. PubMed ID: 22165037
[TBL] [Abstract][Full Text] [Related]
19. Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain.
Hamidi GA; Ramezani MH; Arani MN; Talaei SA; Mesdaghinia A; Banafshe HR
Eur J Pharmacol; 2012 Jan; 674(2-3):260-4. PubMed ID: 22134003
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
Gonzalez MI; Field MJ; Hughes J; Singh L
J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
